Outcomes of the 100 study subjects
| Characteristic | Bromhexine (n=48) | Placebo (n=52) | P value |
| Time to hospital discharge, mean (SD) | 9.1 (3.1) | 9.2 (3.4) | 0.82 |
| ICU admission (days), mean (SD) | 0.6 (2.1) | 0.8 (2.0) | 0.67 |
| No ICU admission and no oxygen, n (%) | 0 (0.0) | 0 (0.0) | – |
| No ICU admission and yes oxygen, n (%) | 43 (89.6) | 47 (90.4) | 1.0 |
| High-flow nasal cannula oxygen, n (%) | 27 (56.3) | 12 (23.1) | 0.001 |
| Intermittent mandatory ventilation, n (%) | 5 (10.4) | 5 (9.6) | 1.0 |
| Duration of supplemental oxygen, mean (SD) | 6.8 (2.2) | 7.0 (3.3) | 0.71 |
| Deaths by day 28, n (%) | 2 (4.2) | 2 (3.9) | 1.0 |
*Data are reported as mean and SD for continuous variables and number (n) and percent for categorical variables.
ICU, intensive care unit.